Skip Navigation

News & Resources

 

Subscribe to NHLBI Press Releases
May 18, 2016

Study shows telomere length in humans can be altered by medical drugs

WHAT:  Scientists at the National Institutes of Health are reporting evidence that human telomeres can be favorably lengthened by medical drug treatment.  Telomeres are the ends of our chromosomes and function to protect them from damage. Over time, telomeres shorten, and this shortening has been linked with increased disease risk. The NIH results appear in this week’s New England Journal of Medicine.

Subscribe to NHLBI In The News
May 25, 2016 : The Lancet

Through a study funded by the National Heart, Lung, and Blood Institute, researchers found that long-term exposure to high levels of air pollution is associated with the acceleration of atherosclerosis — the hardening of coronary arteries. The investigators have not yet identified the biological processes underlying the association, but note that the study supports the case for worldwide pollution reduction efforts to help prevent cardiovascular disease. The study used data from NHLBI’s Multi-Ethnic Study of Atherosclerosis (MESA) for analyses.

May 25, 2016 : The Tom Joyner Morning Show

NHLBI Director Dr. Gary H. Gibbons spoke with radio host Tom Joyner about asthma during National Asthma Awareness Month.  During the 5-minute interview for the Tom Joyner Morning Show, which reaches millions of listeners each week, Dr. Gibbons emphasized important points about asthma, including who it affects, what triggers the disease, and the importance of managing the disease better. 

June 2, 2016 to June 3, 2016
Natcher Conference Center Bethesda, Maryland
Sickle Cell in Focus (SCiF) is an annual two-day intensive and educational conference co-hosted by the National Heart, Lung and Blood Institutes (NHLBI) in Washington, DC and the South Thames Sickle Cell & Thalassaemia Network (STSTN) in London, UK
June 7, 2016 to June 8, 2016
Neuroscience Center Bethesda, Maryland
The 2016 workshop will examine key challenges and proposed recommendations associated with the interface between the circulatory system and the brain. The workshop will include experts from across the spectrum of the blood-brain interface, not just the blood-brain barrier, to highlight the promise and potential of technologies for diagnostics and therapy development. The event will encourage collaborations across the various groups represented at the meeting. Additionally, attendees will have the opportunity to generate a set of recommendations that could facilitate development in this promising field.